Skip to main content

Alternative patient identification: To ensure timely access to medical marijuana, patients who have received application approval may now use their official OMMA approval email or approval in the OMMA MedPortal as a valid form of identification at licensed dispensaries. Read more here: UPDATE: Guidance on Alternative Patient ID

Recall Issued for Products Processed by Sunny Roads Processing 2, LLC

Monday, March 23, 2026

OKLAHOMA CITY, OK — The Oklahoma Medical Marijuana Authority (OMMA) has issued a recall for several medical marijuana pre-roll batches processed by Sunny Roads Processing 2, LLC (PAAA-8JA2-CK1Z).

OMMA received reports of concerns about pre-rolls purchased at Miami Natural Health, LLC. The reports resulted in immediate testing of the products at multiple labs; the products failed testing due to pesticide content above allowable thresholds. OMMA then conducted product tracing to determine that Sunny Roads Processing 2, LLC processed the affected pre-rolls.

A complete list of recalled products and batch numbers is available on our website: Product Recall: March 23, 2026

OMMA is investigating to identify any related products that could be impacted; a notification will be shared as soon as new information is available. 

Information for Patients

Patients who believe they purchased impacted products should: 

  1. Check products: Check the batch number on the product and compare it to the table on the OMMA Recalls page. 
  2. Contact the dispensary: Patients should dispose of recalled products or contact the dispensary where the item was purchased. 
  3. Monitor health: If patients experience an adverse reaction after consuming an impacted product, contact your physician immediately and complete OMMA's Health Impact Form. 
  4. Report violations: Patients who see recalled products on shelves are encouraged to submit a tip via OMMA's Business Complaint Form.

Required Actions for Commercial Licensees

  • Commercial licensees are responsible for notifying any impacted downstream businesses and patients. Dispensaries should remove the recalled products from shelves immediately; these products cannot legally be sold to patients.
  • Recalled products must be disposed of in accordance with OMMA rules. The licensee whose harvest or production batches are being recalled bears responsibility for disposal costs of all waste.
  • The recall process plays an important role in ensuring defective or potentially unsafe products are removed from the commercial market. Recalls are issued when OMMA evaluates test results and other data, leading to the determination that action is necessary.
  • Licensees with questions can reach OMMA via the contact form.
  • Pursuant to OAC 442:10-8-1(g)(2)(C)(vi), a licensee’s failure to timely comply with recall provisions may result in revocation, suspension and monetary penalties.

###

Last Modified on Mar 23, 2026
Back to Top